Citadel Advisors’s Briacell Therapeutics BCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 5959 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 5985 |
|
|
2024
Q3 | – | Sell |
-64
| Closed | -$11K | – | 5820 |
|
|
2024
Q2 | $11K | Buy |
64
+21
| +49% | +$3.61K | ﹤0.01% | 5502 |
|
|
2024
Q1 | $18.4K | Sell |
43
-57
| -57% | -$24.4K | ﹤0.01% | 5567 |
|
|
2023
Q4 | $87.5K | Buy |
+100
| New | +$87.5K | ﹤0.01% | 4918 |
|
|
2023
Q3 | – | Sell |
-424
| Closed | -$409K | – | 5880 |
|
|
2023
Q2 | $409K | Buy |
+424
| New | +$409K | ﹤0.01% | 3822 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6069 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5881 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6008 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6338 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6461 |
|